On June 18, 2024, cornerstone Pharmaceutical held its annual shareholder meeting and passed all nine resolutions, including director election, director remuneration, appointment and remuneration of auditors, and authorization of stock issuance and buyback. Resolutions 1-8 were regular resolutions, while resolution 9 was a special resolution related to the revision of the organizational charter. All resolutions received affirmative votes exceeding the required number. However, Dr. Yang Jianxin, CEO and executive director, was required to abstain from voting on resolution 8 related to the granting of stock options and restricted share units due to his and related parties' ownership of approximately 35.30% of the shares. The revised organizational charter is effective immediately after the meeting, and details have been announced on the company's website and the website of the Hong Kong Stock Exchange.

On June 18, 2024, cornerstone Pharmaceutical held its annual shareholder meeting and passed all nine resolutions, including director election, director remuneration, appointment and remuneration of auditors, and authorization of stock issuance and buyback. Resolutions 1-8 were regular resolutions, while resolution 9 was a special resolution related to the revision of the organizational charter. All resolutions received affirmative votes exceeding the required number. However, Dr. Yang Jianxin, CEO and executive director, was required to abstain from voting on resolution 8 related to the granting of stock options and restricted share units due to his and related parties' ownership of approximately 35.30% of the shares. The revised organizational charter is effective immediately after the meeting, and details have been announced on the company's website and the website of the Hong Kong Stock Exchange.